期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Neoadjuvant therapy for resectable pancreatic cancers
1
作者 Yosuke Inoue hiromichi ito Yu Takahashi 《Hepatobiliary Surgery and Nutrition》 SCIE 2022年第4期583-585,共3页
Pancreatic cancer(PC)is a potentially systemic disease with more diverse biology than generally considered.At present,surgical resection is the only curative therapy available for patients with PC,and its indications ... Pancreatic cancer(PC)is a potentially systemic disease with more diverse biology than generally considered.At present,surgical resection is the only curative therapy available for patients with PC,and its indications have long been discussed based on anatomical resectability.A recent consensus recommends neoadjuvant therapy(NAT)for anatomically borderline resectable(BR)cancers(1)as well as induction therapy for unresectable locally advanced(UR-LA)or metastatic(UR-M)cancers. 展开更多
关键词 CANCERS THERAPY CURATIVE
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部